Inhaltsverzeichnis
Molecular regulation of the ? 2-adrenergic receptor by long- and short-acting ? -agonists. - Molecular interactions between glucocorticoids and ? 2-agonists. - Formoterol, a new long-acting ? 2-agonist. - Development of the long-acting ? 2-agonist, salmeterol. - Development of bambuterol; a long acting, orally active beta-agonist prodrug. - Development of ? 2-receptors in infancy and childhood. - Long-acting beta-agonists in exercise induced asthma. - Salmeterol and oral steroid treatment. - Salmeterol and its relationship to treatment with inhaled corticosteroids. - Long term treatment with formoterol. - Comparison of efficiency of bambuterol and salmeterol. - The future of relievers and controllers in asthma therapy.
